HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tiratricol Use Warning, Recall Alert Subject Of FDA "Talk Paper"

This article was originally published in The Tan Sheet

Executive Summary

FDA is cautioning consumers for a second time against using products containing tiratricol. In a "Talk Paper" issued Nov. 21, the agency cites a series of new recalls, three involving two unapproved new drugs and another relating to an improperly labeled dietary supplement.

You may also be interested in...



FDA Criminal Investigations Of Unapproved Drug Internet Sales Ongoing

FDA's Office of Criminal Investigations has 134 Internet-related investigations under way, 80 of which involve "various types of health fraud or other unapproved drug products" such as GHB. The other 54 cases involve Web sites selling prescription drugs.

Triax Supplement Distribution Barred By Court Order

Dietary supplement marketer Syntrax Innovations is preliminarily barred from making or distributing products containing tiratricol, thyroid hormones or their analogues under a March 3 federal court order.

Triax Weight Loss Supplement Distribution Halted At FDA's Request

The Missouri Department of Health has barred dietary supplement distributor Syntrax Innovations from selling its on-hand supply of a weight loss nutritional supplement due to FDA concerns the product is an unapproved new drug.

Related Content

Topics

UsernamePublicRestriction

Register

RS133356

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel